Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Biological | 25 | 2019 | 1150 | 4.400 |
Why?
|
| Suprachiasmatic Nucleus | 7 | 2021 | 141 | 2.830 |
Why?
|
| Clostridium | 4 | 2021 | 10 | 2.410 |
Why?
|
| Computer Simulation | 17 | 2021 | 463 | 2.260 |
Why?
|
| Metabolic Engineering | 4 | 2019 | 20 | 2.130 |
Why?
|
| Fermentation | 8 | 2021 | 42 | 1.950 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2014 | 534 | 1.630 |
Why?
|
| Bacteria | 4 | 2021 | 278 | 1.600 |
Why?
|
| Glucose | 9 | 2015 | 448 | 1.470 |
Why?
|
| Biofilms | 6 | 2019 | 70 | 1.470 |
Why?
|
| Nerve Net | 4 | 2016 | 91 | 1.460 |
Why?
|
| Biomass | 9 | 2020 | 27 | 1.430 |
Why?
|
| Circadian Rhythm | 7 | 2021 | 375 | 1.420 |
Why?
|
| Metabolic Networks and Pathways | 5 | 2018 | 74 | 1.310 |
Why?
|
| Systems Biology | 4 | 2014 | 28 | 1.240 |
Why?
|
| Ethanol | 6 | 2018 | 308 | 1.200 |
Why?
|
| Models, Neurological | 3 | 2016 | 81 | 1.140 |
Why?
|
| Microbiota | 2 | 2019 | 104 | 1.110 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 204 | 1.050 |
Why?
|
| Biological Clocks | 3 | 2011 | 69 | 1.000 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2016 | 100 | 0.990 |
Why?
|
| Neurons | 5 | 2021 | 864 | 0.960 |
Why?
|
| Escherichia coli | 6 | 2020 | 692 | 0.960 |
Why?
|
| Xylose | 4 | 2014 | 5 | 0.940 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2021 | 78 | 0.940 |
Why?
|
| Genomics | 3 | 2016 | 321 | 0.900 |
Why?
|
| Microbial Consortia | 3 | 2020 | 8 | 0.800 |
Why?
|
| Butyrates | 1 | 2021 | 14 | 0.750 |
Why?
|
| Taxus | 4 | 2019 | 9 | 0.730 |
Why?
|
| Symbiosis | 2 | 2019 | 29 | 0.730 |
Why?
|
| Drug Carriers | 2 | 2013 | 176 | 0.710 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 78 | 0.710 |
Why?
|
| Clostridium Infections | 1 | 2021 | 47 | 0.690 |
Why?
|
| Models, Theoretical | 2 | 2020 | 260 | 0.660 |
Why?
|
| Astrocytes | 1 | 2020 | 116 | 0.650 |
Why?
|
| Wound Infection | 1 | 2019 | 26 | 0.650 |
Why?
|
| Bioreactors | 6 | 2018 | 34 | 0.640 |
Why?
|
| Butylene Glycols | 1 | 2018 | 2 | 0.630 |
Why?
|
| Circadian Clocks | 2 | 2020 | 44 | 0.630 |
Why?
|
| Extracellular Space | 3 | 2016 | 31 | 0.620 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 61 | 0.610 |
Why?
|
| Models, Genetic | 2 | 2016 | 255 | 0.610 |
Why?
|
| Synthetic Biology | 2 | 2016 | 13 | 0.600 |
Why?
|
| Biofuels | 2 | 2020 | 15 | 0.580 |
Why?
|
| Computational Biology | 4 | 2018 | 339 | 0.580 |
Why?
|
| Cell Culture Techniques | 5 | 2019 | 178 | 0.560 |
Why?
|
| Dysbiosis | 1 | 2017 | 57 | 0.550 |
Why?
|
| Coculture Techniques | 4 | 2021 | 95 | 0.530 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2016 | 8 | 0.520 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2017 | 108 | 0.520 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2016 | 43 | 0.510 |
Why?
|
| Genome, Bacterial | 1 | 2015 | 62 | 0.490 |
Why?
|
| Neurospora crassa | 1 | 2015 | 3 | 0.490 |
Why?
|
| Metabolomics | 1 | 2015 | 55 | 0.490 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 162 | 0.490 |
Why?
|
| Glycolysis | 2 | 2007 | 54 | 0.480 |
Why?
|
| Triglycerides | 2 | 2013 | 244 | 0.450 |
Why?
|
| Cell Aggregation | 3 | 2019 | 21 | 0.450 |
Why?
|
| Furaldehyde | 1 | 2013 | 2 | 0.440 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 244 | 0.440 |
Why?
|
| Saccharomycetales | 1 | 2013 | 17 | 0.440 |
Why?
|
| Plant Oils | 1 | 2013 | 57 | 0.430 |
Why?
|
| Oxygen | 3 | 2017 | 313 | 0.380 |
Why?
|
| Nanostructures | 1 | 2013 | 174 | 0.370 |
Why?
|
| Clostridiales | 2 | 2021 | 7 | 0.370 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 735 | 0.360 |
Why?
|
| Intracellular Space | 3 | 2016 | 33 | 0.340 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 2016 | 23 | 0.310 |
Why?
|
| Bacterial Physiological Phenomena | 3 | 2019 | 19 | 0.290 |
Why?
|
| Mammals | 3 | 2020 | 207 | 0.290 |
Why?
|
| Particle Size | 4 | 2013 | 400 | 0.290 |
Why?
|
| Metabolic Flux Analysis | 2 | 2016 | 6 | 0.270 |
Why?
|
| Biotechnology | 1 | 2006 | 42 | 0.260 |
Why?
|
| Nanoparticles | 1 | 2012 | 496 | 0.250 |
Why?
|
| Paclitaxel | 3 | 2011 | 92 | 0.250 |
Why?
|
| Algorithms | 4 | 2015 | 1019 | 0.250 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 1598 | 0.240 |
Why?
|
| Microbiology | 1 | 2003 | 4 | 0.220 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2013 | 31 | 0.210 |
Why?
|
| Crystallization | 2 | 2013 | 97 | 0.210 |
Why?
|
| Models, Chemical | 3 | 2012 | 138 | 0.200 |
Why?
|
| Yeasts | 1 | 2002 | 51 | 0.200 |
Why?
|
| Humans | 12 | 2021 | 61135 | 0.200 |
Why?
|
| Receptors, GABA | 1 | 2021 | 12 | 0.190 |
Why?
|
| Eubacterium | 1 | 2021 | 1 | 0.190 |
Why?
|
| Kinetics | 3 | 2012 | 755 | 0.190 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 17 | 0.180 |
Why?
|
| Enterobacteriaceae | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cellobiose | 1 | 2020 | 2 | 0.180 |
Why?
|
| Plankton | 1 | 2020 | 3 | 0.180 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 61 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 20 | 0.180 |
Why?
|
| Feces | 1 | 2021 | 96 | 0.180 |
Why?
|
| Cluster Analysis | 1 | 2021 | 253 | 0.170 |
Why?
|
| Diffusion | 3 | 2016 | 84 | 0.160 |
Why?
|
| Animals | 6 | 2020 | 20116 | 0.160 |
Why?
|
| Geobacter | 1 | 2019 | 12 | 0.160 |
Why?
|
| Coinfection | 1 | 2019 | 44 | 0.160 |
Why?
|
| Hydrodynamics | 1 | 2018 | 33 | 0.150 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2017 | 1 | 0.150 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2017 | 1 | 0.150 |
Why?
|
| Signal Transduction | 5 | 2011 | 2910 | 0.150 |
Why?
|
| Genetic Enhancement | 1 | 2016 | 2 | 0.140 |
Why?
|
| Biological Transport | 2 | 2016 | 288 | 0.140 |
Why?
|
| Biosynthetic Pathways | 1 | 2016 | 18 | 0.140 |
Why?
|
| Hydrogen | 1 | 2016 | 51 | 0.130 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 287 | 0.130 |
Why?
|
| Carbon Dioxide | 1 | 2016 | 85 | 0.130 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2016 | 11 | 0.130 |
Why?
|
| Metabolome | 1 | 2015 | 27 | 0.130 |
Why?
|
| Triolein | 1 | 2013 | 3 | 0.110 |
Why?
|
| Palm Oil | 1 | 2013 | 5 | 0.110 |
Why?
|
| Suspensions | 1 | 2013 | 9 | 0.110 |
Why?
|
| Flocculation | 1 | 2013 | 13 | 0.110 |
Why?
|
| Olive Oil | 1 | 2013 | 7 | 0.110 |
Why?
|
| Caprylates | 1 | 2013 | 12 | 0.110 |
Why?
|
| Alkanes | 1 | 2013 | 15 | 0.110 |
Why?
|
| Oleic Acid | 1 | 2013 | 21 | 0.110 |
Why?
|
| Phase Transition | 1 | 2013 | 19 | 0.110 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2013 | 5 | 0.110 |
Why?
|
| Biotransformation | 1 | 2013 | 23 | 0.110 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Polysorbates | 1 | 2013 | 39 | 0.110 |
Why?
|
| Drug Stability | 1 | 2013 | 141 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 134 | 0.110 |
Why?
|
| Amino Acids | 2 | 2020 | 141 | 0.100 |
Why?
|
| Surface-Active Agents | 1 | 2013 | 112 | 0.100 |
Why?
|
| Drug Storage | 1 | 2012 | 21 | 0.100 |
Why?
|
| Aerobiosis | 1 | 2011 | 8 | 0.100 |
Why?
|
| Darkness | 1 | 2011 | 22 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 932 | 0.090 |
Why?
|
| Cell Division | 2 | 2003 | 441 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 1123 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 41 | 0.090 |
Why?
|
| Drug Compounding | 1 | 2012 | 75 | 0.090 |
Why?
|
| Photic Stimulation | 1 | 2011 | 89 | 0.090 |
Why?
|
| Chlorides | 1 | 2011 | 32 | 0.090 |
Why?
|
| Organisms, Genetically Modified | 1 | 2011 | 8 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 1109 | 0.090 |
Why?
|
| Young Adult | 1 | 2021 | 4414 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 87 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5554 | 0.090 |
Why?
|
| Cytosol | 1 | 2011 | 171 | 0.090 |
Why?
|
| Adolescent | 1 | 2021 | 6029 | 0.080 |
Why?
|
| Quorum Sensing | 1 | 2008 | 8 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 557 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 297 | 0.070 |
Why?
|
| Ecosystem | 1 | 2008 | 40 | 0.070 |
Why?
|
| Cell Count | 2 | 2010 | 130 | 0.070 |
Why?
|
| Acetaldehyde | 1 | 2007 | 3 | 0.070 |
Why?
|
| Anaerobiosis | 1 | 2007 | 15 | 0.070 |
Why?
|
| Stochastic Processes | 1 | 2007 | 26 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2107 | 0.070 |
Why?
|
| Energy Metabolism | 2 | 2008 | 362 | 0.070 |
Why?
|
| NAD | 1 | 2007 | 50 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2008 | 150 | 0.070 |
Why?
|
| Aged | 2 | 2021 | 14129 | 0.070 |
Why?
|
| Cell Communication | 1 | 2007 | 128 | 0.070 |
Why?
|
| Proteome | 1 | 2007 | 142 | 0.070 |
Why?
|
| Spheroids, Cellular | 1 | 2006 | 26 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2008 | 384 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 722 | 0.060 |
Why?
|
| Adult | 2 | 2021 | 16196 | 0.060 |
Why?
|
| Middle Aged | 2 | 2021 | 16831 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 456 | 0.060 |
Why?
|
| Hydrogen Sulfide | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2004 | 21 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2006 | 310 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 424 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 197 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 77 | 0.050 |
Why?
|
| Cell Survival | 2 | 2019 | 849 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1128 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2069 | 0.050 |
Why?
|
| Mutation | 1 | 2009 | 2474 | 0.040 |
Why?
|
| Homeostasis | 1 | 2002 | 348 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 3658 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 1263 | 0.040 |
Why?
|
| Peptides | 1 | 2020 | 552 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 118 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1238 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 21 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 35 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 140 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2008 | 187 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 48 | 0.020 |
Why?
|
| Contrast Media | 1 | 2010 | 415 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1061 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 184 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 286 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2006 | 210 | 0.020 |
Why?
|
| Cell Death | 1 | 2006 | 271 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1549 | 0.010 |
Why?
|
| Female | 1 | 2010 | 31658 | 0.000 |
Why?
|